Business
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
IRVING, Texas, Nov. 21, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision
About this update from Caris Life Sciences, Inc.
[{"type":"text","content":"IRVING, Texas, Nov. 21, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the selection of 15 physician-scientists to participate in its 2025/2026 Caris Precision Oncology Alliance (Caris POA) Fellows Forum. This competitive two-year program provides early-career oncologists with hands-on training, mentorship and access to real-world molecular data, empowering them to develop and test clinically meaningful precision medicine hypotheses.\n \n \n \n \n \n \n \nTo be considered for the program, applicants must be physician-scientists in their first or second year of oncology fellowship at one of Caris' POA institutions. Caris POA fellows were chosen through a competitive review process evaluating academic achievements and research track record, interest and potential in molecular oncology. Those accepted into the Fellows Forum will experience:Direct mentorship from Caris experts and leading faculty at Caris POA institutionsAccess to Caris' CODEai database (catalog of molecular data with cancer treatment information and clinical outcomes data for more than 484,000 patients, covering greater than one million data points per patient)Collaborative research projects spanning over 97 cancer institutions and research consortiaStructured educational modules, virtual webinars and lab tours\"Investing in the next generation of oncology leaders allows us to advance research while also accelerating discoveries that will change how we diagnose and treat cancer,\" said James Hamrick, MD, MPH, Chairman of the Caris Precision Oncology Alliance. \"This year's class represents the future of precision oncology and we're excited to support their journey.\"Fellows dedicate time monthly alongside their ongoing clinical or academic duties, participating in data analysis, seminars and mentorship sessions that sharpen their expertise in molecular oncology.Fellows Forum members will convene periodically to foster community and exchange insights, including a guided tour of Caris' Blood and Tissue Labs in Phoenix, the Caris POA Summit at the ASCO Annual Meeting and via monthly virtual workshops for research updates and skill-building. These gatherings reinforce a shared theme to translate molecular insights into improved patient outcomes world...